Investment
Features
FeesSafety
Academy
More
Pluang+

First Phosphorus gains on strong permits, funding, and upcoming feasibility study.

Market News
07 Aug 2026
Seeking Alpha
View Source
Bullish
First Phosphorus gains on strong permits, funding, and upcoming feasibility study.

First Phosphorus Corp. (FRSPF) is rated a Buy for investors willing to accept high risk for high reward, supported by recent permitting and feasibility milestones. The company benefits from strong government backing, including C$16.7 million in non-repayable grants and fast-track regulatory status, which reduce project risks. Its financial position is solid for a pre-revenue firm, with assets exceeding liabilities by over five times and cash covering liabilities threefold despite increased exploration costs. The upcoming feasibility study is a key catalyst, offering significant upside potential before its release, though risks remain related to political support and phosphorus market prices.

More News

Trading on Hyperliquid in Germany is legal for individuals but lacks EU regulatory protections.

Trading on Hyperliquid in Germany is legal for individuals but lacks EU regulatory protections.

In Germany, private individuals can legally trade on Hyperliquid, a platform mainly offering perpetual futures, without committing an offense. However, Hyperliquid is not authorized under the EU's MiCA regulation because it deals in derivatives class...

Market News
Neutral
4 hours ago
Golden Sky Minerals finds strong copper soil anomalies linked to intrusive rocks at Rayfield-Gjoll project.

Golden Sky Minerals finds strong copper soil anomalies linked to intrusive rocks at Rayfield-Gjoll project.

Golden Sky Minerals reported strong copper-in-soil anomalies at its Rayfield-Gjoll Project in British Columbia, closely associated with intrusive rocks like diorite and monzonite. These findings support a porphyry copper-gold exploration model and hi...

Market News
Bullish
4 hours ago
Low side effects and improved treatment experience reported for RYBREVANT FASPRO plus LAZCLUZE in advanced lung cancer

Low side effects and improved treatment experience reported for RYBREVANT FASPRO plus LAZCLUZE in advanced lung cancer

Johnson & Johnson announced positive Phase 2b COPERNICUS study results showing low rates of rash, blood clots, and administration-related reactions with subcutaneous RYBREVANT FASPRO plus LAZCLUZE in treating advanced non-small cell lung cancer with ...

Market News
Bullish
4 hours ago
Oil prices and 10-year Treasury yields hit strongest correlation since 2019, pressuring markets and inflation.

Oil prices and 10-year Treasury yields hit strongest correlation since 2019, pressuring markets and inflation.

Oil prices and 10-year Treasury yields are moving in near lockstep, with their correlation reaching 0.96—the highest since 2019. This tight relationship is driven by rising oil prices due to Middle East tensions, pushing inflation expectations and Tr...

Market News
Bearish
4 hours ago
Rose's Income Garden portfolio gains 12.07% YTD with strong dividend yields from preferred shares and REITs

Rose's Income Garden portfolio gains 12.07% YTD with strong dividend yields from preferred shares and REITs

Rose's Income Garden (RIG) portfolio, consisting of 72 holdings across all 11 GISC sectors plus a personal preferred shares sector, achieved a 12.07% year-to-date gain and offers a 5.76% forward yield as of August 2026. Key income-focused investments...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App